Published in Pathology on February 01, 2013
Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. J Clin Microbiol (2013) 0.91
Evaluation of the automated Vitek 2 system for detection of various mechanisms of macrolide and lincosamide resistance in Staphylococcus aureus. J Clin Microbiol (2014) 0.75
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
Malaria acquired in Bali. Med J Aust (1995) 1.93
Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage--sensitive but not specific. J Antimicrob Chemother (2007) 1.88
Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother (2005) 1.81
Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet (2001) 1.60
Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis (2013) 1.60
Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother (2005) 1.58
Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Aust N Z J Med (1992) 1.52
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42
The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes. Clin Exp Immunol (1985) 1.39
HIV in the suburbs. Med J Aust (1993) 1.38
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother (1996) 1.36
In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol (1995) 1.34
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis (2010) 1.32
High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother (2008) 1.29
Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro. Clin Exp Immunol (1986) 1.27
A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis (2009) 1.25
Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol (1995) 1.25
Protein S alters the active site location of activated protein C above the membrane surface. A fluorescence resonance energy transfer study of topography. J Biol Chem (1997) 1.24
In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent. Diagn Microbiol Infect Dis (1991) 1.19
Acute arthritis associated with Clostridium difficile colitis. Br Med J (Clin Res Ed) (1981) 1.18
Psittacosis--a review of 135 cases. Med J Aust (1988) 1.17
ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods (1987) 1.16
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust (2001) 1.15
Optimum treatment of staphylococcal infections. Drugs (1993) 1.13
Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA. J Clin Microbiol (2009) 1.09
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect (2013) 1.09
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. Pathology (1997) 1.09
Vancomycin vintage: my favourite DRESS. Intern Med J (2015) 1.08
It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia. Intern Med J (2014) 1.07
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 1.07
Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol (2008) 0.99
Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis (2000) 0.97
Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut (1991) 0.97
Assessing the risk of tuberculosis infection among healthcare workers: the Melbourne Mantoux Study. Melbourne Mantoux Study Group. Med J Aust (2001) 0.96
Smoking and varicella pneumonia. J Infect (1988) 0.95
Severe dapsone syndrome due to weekly maloprim. Lancet (1988) 0.93
Home-based treatment of cellulitis with twice-daily cefazolin. Med J Aust (1998) 0.93
Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol (2009) 0.93
The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother (1999) 0.93
Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother (1997) 0.91
A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. Thorax (2000) 0.90
Hospital-in-the-home care: is it worth the hassle? Med J Aust (1998) 0.89
Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing. J Infect (1997) 0.88
Immunoglobulin production by coeliac biopsies in organ culture. Gut (1986) 0.87
Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir. Antimicrob Agents Chemother (2013) 0.86
Isoniazid toxicity in health care workers. Clin Infect Dis (1999) 0.83
Neurological complications of chlamydial infections: case report and review. Clin Infect Dis (1997) 0.83
Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme. J Hosp Infect (2012) 0.81
The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia. Infect Control Hosp Epidemiol (2001) 0.81
Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Am J Trop Med Hyg (1999) 0.80
Prevalence of primary lactase deficiency in adult residents of west Birmingham. BMJ (1993) 0.80
Can alcohol-based hand-rub solutions cause you to lose your driver's license? Comparative cutaneous absorption of various alcohols. Antimicrob Agents Chemother (2006) 0.79
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis (1997) 0.78
Effect of anti-tuberculosis treatment on the tuberculin interferon-gamma response in tuberculin skin test (TST) positive health care workers and patients with tuberculosis. Int J Tuberc Lung Dis (2000) 0.78
Acceptability of early discharge, hospital at home schemes. Treatments that can be safely and acceptably managed at home need to be defined. BMJ (1998) 0.78
Safety of imipenem in neonates. Pediatr Infect Dis J (1995) 0.78
Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clin Microbiol Infect (2012) 0.77
Cure of Rhizopus sinusitis in a liver transplant recipient with liposomal amphotericin B. Clin Infect Dis (1993) 0.77
Low rates of cutaneous adverse reactions to alcohol-based hand hygiene solution during prolonged use in a large teaching hospital. Antimicrob Agents Chemother (2005) 0.77
Vibrio cholerae in Victoria. Med J Aust (2000) 0.77
Monoclonal gammopathy and septic arthritis. Aust N Z J Med (1999) 0.76
Ochratoxin A in wheat: an intercomparison of procedures. Food Addit Contam (1993) 0.76
Pneumococcal arthritis and monoclonal gammopathy of undetermined significance. Aust N Z J Med (1997) 0.76
The difference between biological warfare and bioterrorism: Australia finally makes a start towards real preparedness for bioterrorism. Intern Med J (2003) 0.75
Prolonged dystonic reaction to chlorpromazine in myxoedema coma. Postgrad Med J (1980) 0.75
"Angiodysplasia' of the tongue with acquired von Willebrand's disease. Postgrad Med J (1982) 0.75
Still awaiting a useful tool for predicting severe CAP. Thorax (2006) 0.75
A potential "blind spot" in vancomycin treatment studies. Clin Infect Dis (2012) 0.75
The relation between skin histamine concentration, histamine sensitivity, and the resistance of cattle to the tick, Boophilus microplus. Z Parasitenkd (1979) 0.75
Malaria acquired in Bali. Med J Aust (1995) 0.75
Organ culture of fetal rat small intestine for testing gluten toxicity: a reappraisal. Br J Exp Pathol (1987) 0.75
Pleurisy and pulmonary granulomas after treatment with acebutolol. Br Med J (Clin Res Ed) (1982) 0.75
Conservative management of a transdiaphragmatic fistula. Thorax (2000) 0.75
Chronic hepatitis B carriers found at blood donation: do they need regular follow-up? Vox Sang (1987) 0.75
Health care workers and tuberculosis. Aust N Z J Med (2000) 0.75
Breastfeeding and the risk of vertical transmission of hepatitis C virus. Med J Aust (1995) 0.75
Treatment of urinary tract infections. Aust Fam Physician (1995) 0.75
Outbreak of vancomycin-resistant Enterococcus faecium containing both vanA and vanB gene clusters. J Hosp Infect (2009) 0.75
The risk of exotic and native plants as hosts for four pest thrips (Thysanoptera: Thripinae). Bull Entomol Res (2010) 0.75
Neurocysticercosis and new-onset seizures in short term travellers to Bali. Med J Aust (1994) 0.75
Chronic liver disease. A case control study of the effect of previous blood transfusion. Public Health (1989) 0.75
Economic and educational status of zidovudine recipients in Melbourne. Med J Aust (1990) 0.75
The preparation, validation and certification of the aflatoxin content of two peanut butter reference materials. Food Addit Contam (1992) 0.75
Cerebral sparganosis in an East Timorese refugee. Med J Aust (1994) 0.75
Fistula-in-ano: don't forget tuberculosis. Med J Aust (1997) 0.75
The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia. Intern Med J (2007) 0.75
A review of isoniazid-related hepatotoxicity during chemoprophylaxis. Aust N Z J Med (1999) 0.75